ANDA 75021, held by Teva Pharms. Acyclovir.
As of Nov 13, 2026, ANDA 75021 (Acyclovir), held by Teva Pharms, was first approved by FDA on Mar 18, 1998, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 18, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
